Streetbeat News

OCPNY

Olympus Corp.

https://www.olympus.co.jp/

CEO

Yasuo Takeuchi

Industry

Surgical and Medical Instrument Manufacturing

Open

18.00

Mkt cap

N/A

Volume

465

High

18.00

P/E Ratio

N/A

52-wk high

74.99

Low

18.00

Div yield

0.01

52-wk low

16.80

Monroe Capital LLC has acted as a joint lead arranger in providing a senior credit facility to support Olympus Partners' acquisition of PAI Pharma, a prominent US-based oral generic liquids manufacturer. PAI, founded in 1968 and located in Greenville, SC, is known for its extensive portfolio of generic oral liquid medicines serving various healthcare sectors.

Portfolio Pulse from

April 08, 2025 | 10:15 am

Portfolio Pulse from

April 08, 2025 | 10:15 am

Monroe Capital LLC has acted as a joint lead arranger for a senior credit facility to support Olympus Partners' acquisition of Accelevation Holding Company, LLC. Accelevation provides infrastructure products and services to the data center market.

Portfolio Pulse from

February 18, 2025 | 11:15 am

Olympus Corporation (OTCPK:OLYMY) held its Q3 2025 earnings call, discussing financial results and strategic directions. Key executives participated, and analysts from major financial institutions attended.

Portfolio Pulse from

February 14, 2025 | 10:30 pm

Olympus Corporation (OTCPK:OLYMY) held its Q2 2025 earnings call, discussing company performance and future outlook. Key executives participated, and analysts from major financial institutions were present.

Portfolio Pulse from

November 09, 2024 | 1:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.